🔎 Trials Near Me

Home › Breast Cancer › New York › Syracuse

Breast Cancer clinical trials in Syracuse, NY

5 studies for Breast Cancer are looking for participants at sites in and around Syracuse (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

RecruitingPhase 2
  • Hematology Oncology Associates of Central New York, Camillus · 8 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07102381

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

RecruitingPhase 3
  • Hematology Oncology Associates of Central New York, PC, East Syracuse · 4 mi away
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06492616

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

RecruitingPhase 3
  • State University of New York Upstate Medical University, Syracuse
  • Upstate Cancer Center at Hill Radiation Oncology, Syracuse
  • SUNY Upstate Medical Center-Community Campus, Syracuse
  • and 2 more
Ages 50 to 70 · All sexes · Updated Apr 23, 2026 · NCT04852887

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

RecruitingObservational study
  • SUNY Upstate Medical University Hospital, Syracuse
Ages 18 and older · All sexes · Updated Aug 20, 2025 · NCT03053193

About Breast Cancer

Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.

More about Breast Cancer on MedlinePlus

Breast Cancer trials in other cities

Other studies in Syracuse

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.